TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM, respectively.  TW-37 inhibits the growth of a broad range of cancer cells (such as breast, prostate, lymphoma, and pancreatic cancer

Numéro d'article : BIOV2789-5
Unité de mesure : 5 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923760/image_1920?unique=2abe58c

146.00 CHF 146.0 CHF 146.00 CHF

146.00 CHF

Not Available For Sale

    Cette combinaison n'existe pas.

    Délai de livraison actuel sur demande

    Fabricant : BIOVISION
    Numéro du fabricant : 2789-5
    Température de stockage : Freezer (-20)

    TW-37 is a novel nonpeptide inhibitor to recombinant Bcl-2, Bcl-xL and Mcl-1 with Ki of 0.29 μM, 1.11 μM and 0.26 μM, respectively.  TW-37 inhibits the growth of a broad range of cancer cells (such as breast, prostate, lymphoma, and pancreatic cancer